NVIDIA vs Pfizer: Founders, CEOs and History
NVIDIA was founded in 1993 by Jensen Huang, Chris Malachowsky, Curtis Priem and is led by Jensen Huang. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.
Company facts
Founders
NVIDIA
Jensen Huang
Nvidia possesses a gritty, prescient founding story, rooted entirely in a specific, technical conversation at a well-known American diner, and driven by a CEO who possessed an unshakable conviction in an unproven computational theory.
Chris Malachowsky
Chris Malachowsky co-founded NVIDIA in 1993 and became a central figure in the company's technical foundation.
Curtis Priem
Curtis Priem co-founded NVIDIA in 1993 and served as one of the company's original architects.
Pfizer
Charles Pfizer
Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.
Charles Erhart
Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…
CEOs and their tenures
NVIDIA
- Jensen Huang1993–present
CEO
Huang has been CEO for more than 33 years, which makes him one of the longest-serving founder-CEOs in the industry. Under him NVIDIA bet early on CUDA and deep learning, bought Mellanox for networking, and moved to a yearly architecture cadence.
Source - Chris Malachowsky1993–2024
Co-Founder
Chris Malachowsky co-founded Nvidia in 1993. As Senior Vice President of Engineering and Operations, he played a critical role in developing the early graphics processing architecture and establishing Nvidia's robust engineering supply chain.
Source - Colette Kress2013–present
Executive Vice President and Chief Financial Officer
She has been CFO through NVIDIA's growth from about $4B of annual revenue to $215.9B in FY2026, and she leads its quarterly earnings communication with investors.
Source
Pfizer
- Ian Read2010–2018
Chief Executive Officer
He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.
Source - Albert Bourla2019–present
Chairman and Chief Executive Officer
A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
Source - Dave Denton2022–2026
Chief Financial Officer
As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.
Source - Chris Boshoff2025–present
Chief Scientific Officer and President, Research & Development
He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.
Source - Cecile Guegan2026–present
Interim Chief Financial Officer
She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.
Source
Timeline: NVIDIA and Pfizer side by side
1849Pfizer
Pfizer Founded
Charles Pfizer and Charles Erhart founded the company in Brooklyn.
1944Pfizer
Penicillin Scale-Up
Pfizer helped industrialize penicillin production during World War II.
1993NVIDIA
Founding in Santa Clara
Jensen Huang, Chris Malachowsky, and Curtis Priem founded NVIDIA on April 5, 1993, with a focus on 3D graphics for gaming and multimedia. The founding set the company on a parallel-processing path long before AI infrastructure became the main market.
1998Pfizer
Viagra Approved
The FDA approved Viagra in 1998.
1999NVIDIA
GPU Category Defined
NVIDIA introduced the graphics processing unit concept in 1999. The milestone mattered because it framed graphics hardware as a specialized processor, a technical idea that later carried into accelerated computing and AI workloads.
2000Pfizer
Warner-Lambert Deal
Pfizer acquired Warner-Lambert, adding Lipitor.
2006NVIDIA
CUDA Opens GPUs to General Computing
CUDA opened GPU parallel processing to scientists, researchers, and developers outside graphics. It became the software foundation that made NVIDIA hardware useful for machine learning, simulation, and other compute-heavy workloads.
2012NVIDIA
AlexNet Shows GPU Value for Deep Learning
The AlexNet breakthrough used NVIDIA GPUs to win the ImageNet competition. The event helped convince researchers and engineers that GPUs could accelerate neural-network training at a scale CPUs could not match.
2016NVIDIA
DGX-1 AI Supercomputer
Nvidia introduced the DGX-1 deep-learning supercomputer in 2016, its first system built specifically for artificial intelligence.
2018NVIDIA
RTX Brings Real-Time Ray Tracing to Graphics
NVIDIA RTX brought real-time ray tracing into the company's graphics roadmap. The product line kept gaming and professional visualization tied to AI-enhanced rendering while Data Center was becoming more important.
2019Pfizer
Albert Bourla becomes CEO
Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
2020NVIDIA
Mellanox Acquisition Adds Networking
NVIDIA completed the Mellanox acquisition for about $7 billion. The deal mattered because large AI and high-performance-computing clusters depend on fast networking between accelerators, not only on individual GPU speed.
2020Pfizer
BioNTech COVID Vaccine Partnership
Pfizer and BioNTech brought Comirnaty through emergency authorization.
2022NVIDIA
Arm Acquisition Terminated
NVIDIA and SoftBank terminated the proposed Arm acquisition because of significant regulatory challenges. The failed deal showed how closely governments watch control points in semiconductor architecture.
2022NVIDIA
Hopper H100 Announced
Nvidia announced the Hopper-architecture H100 data-center GPU in March 2022.
2023NVIDIA
Grace CPU Enters Data Center Roadmap
NVIDIA introduced its first data-center CPU, Grace, for large-scale AI and high-performance computing. The milestone expanded the platform from GPUs and networking into CPU-GPU system design.
2023Pfizer
Seagen Acquisition
Pfizer completed the $43 billion Seagen acquisition.
2024NVIDIA
Blackwell Architecture Launched
NVIDIA launched Blackwell as a data-center-scale architecture combining GPUs, CPUs, DPUs, interconnects, switch chips, systems, and networking adapters. The architecture became central to FY2026 Data Center demand.
2025Pfizer
Chris Boshoff Becomes CSO
Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
2025Pfizer
Metsera Acquisition
Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.
2025Pfizer
FY2025 Revenue Base
Pfizer reported $62.579 billion of FY2025 revenue.
2026NVIDIA
$215.9B FY2026 Revenue
NVIDIA reported $215.9 billion of FY2026 revenue, $193.7 billion of Data Center revenue, and $120.1 billion of net income. The result showed how far AI infrastructure had moved the company beyond its original PC graphics market.
2026Pfizer
Innovent Oncology Collaboration
Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.
Acquisitions
NVIDIA
- Groq (technology license and team)2025Undisclosed
- Run:ai2024$700M
- Excelero2022Undisclosed
- Mellanox Technologies2020$6.9B
- Cumulus Networks2020Undisclosed
- Icera2011$367M
Pfizer
- Metsera, Inc.2025$7B
- Seagen Inc.2023$43B
- Medivation Inc.2016$14B
- Wyeth2009$68B
- Pharmacia Corporation2003$60B
- Warner-Lambert Company2000$111B
Questions about NVIDIA vs Pfizer
Who is the CEO of NVIDIA Corporation and Pfizer Inc.?
NVIDIA Corporation is led by Jensen Huang and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was NVIDIA Corporation founded vs Pfizer Inc.?
Pfizer Inc. was founded in 1849 — 144 years before NVIDIA Corporation, which was founded in 1993. Pfizer Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger NVIDIA Corporation.
How many employees does NVIDIA Corporation have compared to Pfizer Inc.?
NVIDIA Corporation employs approximately 42,000 people, while Pfizer Inc. employs approximately 75,000. Pfizer Inc. has the larger workforce at 75,000 employees, compared to NVIDIA Corporation's 42,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are NVIDIA Corporation and Pfizer Inc. headquartered?
Both NVIDIA Corporation and Pfizer Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded NVIDIA Corporation and Pfizer Inc.?
NVIDIA Corporation was founded by Jensen Huang, Chris Malachowsky, Curtis Priem. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.
Which company has a longer operating history — NVIDIA Corporation or Pfizer Inc.?
Pfizer Inc. has been operating for approximately 177 years, making it the more established of the two companies. NVIDIA Corporation has been in operation for around 33 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the NVIDIA vs Pfizer overview